Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Several things can cause sacroiliitis, which is an inflammatory joint condition. There are differences in age, gender, and spondyloarthritis. The number of illnesses and how often they happen affect the market demand for testing tools and medicines.
Diagnostic imaging techniques, such as MRI and CT studies, can find sacroiliitis early on. This has caused a huge demand for testing instruments.
Access to and effectiveness of medicines like NSAIDs and biologics, physical therapy, and surgery all have an impact on how well patients do and how much healthcare costs.
Pathophysiology studies and new treatments for sacroiliitis are what move the market. These factors affect spending and competition in the pharmaceutical business.
The rise of the market is affected by healthcare centers and experts who can diagnose and treat sacroiliitis. These are especially true in places where there aren't many medical services.
The rules that control the approval and selling of sacroiliitis therapies affect how easy it is to get into the market, how competitive it is, and how drug companies set their prices.
Awareness efforts and training programs for patients, caregivers, and healthcare professionals promote early identification and treatment, which changes the way the market works.
Getting care for sacroiliitis depends on a lot of social and economic factors. Things that matter are income, health care prices, and insurance. These factors change the price and demand on the market.
Because sacroiliitis often happens with other conditions like psoriasis and inflammatory bowel disease, patients need care that takes into account their whole health. This affects the market desire for combined treatment methods.
The sacroiliitis business is driven by the chance for developing countries to grow their markets. These chances come from better healthcare facilities, higher spending wages, and a better knowledge of chronic inflammation diseases.
Sacroiliitis drugmakers compete with each other, which affects prices, new ideas, and market share. There are brand-name, generic, biosimilar, and other drugs for sale by these businesses.
Sacroiliitis rates are going up because people are living longer in rich countries and people's lives are changing all over the world. This makes the market grow and increases the need for healthcare services that are connected.
Coverage for sacroiliitis tests and treatments by insurance affects how easy it is for patients to get care and pay for it, as well as market demand and the decisions made by healthcare providers.
Public health measures led by the government to stop and treat long-term inflammatory diseases like sacroiliitis change the way the market works. Policy acts are what pay for and run these services.
Managing sacroiliitis well leads to better results and quality of life for patients, which increases the need for new drugs and support services.
Sacroiliitis Market Highlights:
Sacroiliitis Market Scenario
The Sacroiliitis Market is projected to reach USD 0.65 Billion by 2030 at 19.10% CAGR during the forecast period 2022-2030. Sacroiliitis is a medical condition where there is inflammation in one or both sacroiliac joints situated in the pelvis and lower back. The function of a sacroiliac joint is to bear the weight of the upper body while standing, walking, and others. The condition can be diagnosed by imaging techniques. Sacroiliitis is caused due to traumatic injury, arthritis, pregnancy, infection, spondylitis, and others. The increasing prevalence of arthritis is the key factor for the market growth. According to the Centers for Disease Control and Prevention (2013to 2015), 22.7% Americans of the total population had arthritis, annually. Thus, such a high prevalence of arthritis and increasing government funding for the healthcare sector enhance the growth of this market.
However, factors such as expensive diagnostic tests and the high cost of surgical procedures are expected to restrict the market growth during the forecast period.
Segmentation
The sacroiliitis market is segmented on the basis of diagnosis, treatment, and end-user. The sacroiliitis industry, by diagnosis, is sub-segmented into imaging tests and anesthetic injections. The imaging tests category includes x-ray, MRI, and CT scan. On the basis of treatment, the market is categorized into medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic manipulation, and physical therapy. On the basis of end-user, the market is segmented into hospitals and clinics, pharmacies, and diagnostic centers.
On the basis of region, the sacroiliitis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players in the sacroiliitis market are Medacta International, SI-BONE, Globus Medical, Zyga Technology, Nutech Medical, CoorsTek Medical LLC, Aspen Medical Products, Medtronic, and others.
Regional Market Summary
Sacroiliitis Market Share (%), by Region, 2017
Sources: Centers for Disease Control and Prevention
The sacroiliitis market is dominated by North America owing to the high prevalence of arthritis and high healthcare investments within this region. According to the Centers for Disease Control and Prevention by 2040, 78.4 million will have doctor-diagnosed arthritis.
The rising adoption of technologically advanced systems for early diagnosis of diseases also drives the market growth in this region.
It is estimated that Europe stood second in the sacroiliitis market. The increasing prevalence of lower back disorders and the availability of minimally invasive surgical procedures for sacroiliitis drive the market growth in this region. According to The European (2015), sacroiliac joint was the main reason for chronic low back pain in Europe.
Asia-Pacific was projected to be the fastest growing region for the sacroiliitis market. Key factors such as the growing patient pool, the high prevalence of chronic diseases, developing healthcare infrastructure, and increasing research and development activities in the biotechnology sector influence the market in this region. The presence of major market players such as China, India, and Japan drives the market growth.
The Middle East and Africa holds the least share of the sacroiliitis market due to the presence of stringent government policies and poor economies. However, growing awareness among the population, rising government initiatives to improve the healthcare sector, and high investments by private market players in this region can boost the market growth.Â
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Market Segmentation and Key Market Players
Sacroiliitis Market, by Diagnosis,
- Imaging tests
- X-ray
- MRI
- CT scan
- Anesthetic injections
Sacroiliitis Market, by Treatment
- Medications
- Pain relievers
- Muscle relaxants
- TNF inhibitors
- Joint injections
- Radiofrequency denervation
- Electrical stimulation
- Joint fusion
- Facet block
- Chiropractic manipulation
- Physical therapy
Sacroiliitis Market, by End-User
- Hospitals & Clinics
- Pharmacies
- Diagnostic Centers
Sacroiliitis Market, by Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Sacroiliitis Market, by Key Players
- Medacta International
- SI-BONE
- Globus Medical
- Zyga Technology
- Nutech Medical
- CoorsTek Medical LLC
- Aspen Medical Products
- Medtronic
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
